$\require{mediawiki-texvc}$
  • 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색도움말
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"

통합검색

도움말도움말
상세검색 다국어 입력

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

특허 상세정보

MyON담기
내보내기 페이스북 공유 카카오톡 공유

Methods for eliciting or enhancing reactivity to HER-2/neu protein

특허상세정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판) A61K-038/17   
미국특허분류(USC) 514/02 ; 514/021
출원번호 US-0625101 (1996-04-01)
발명자 / 주소
출원인 / 주소
대리인 / 주소
    Seed and Berry LLP
인용정보 피인용 횟수 : 84  인용 특허 : 9
초록

Compounds and compositions for eliciting or enhancing immune reactivity to HER-2/neu protein are disclosed. The compounds include polypeptides and nucleic acid molecules encoding such peptides. The compounds may be used for the prevention or treatment of malignancies in which the HER-2/neu oncogene is associated.

대표
청구항
▼

[ We claim:] [1.] A method for eliciting or enhancing an immune response to HER-2/neu protein, comprising administering to a human in an amount effective to elicit or enhance said response a polypeptide encoded by a DNA sequence selected from:(a) nucleotides 2026 through 3765 of SEQ ID NO: 1; and(b) DNA sequences that hybridize to a nucleotide sequence complementary to nucleotides 2026 through 3765 of SEQ ID NO:1 under moderately stringent conditions, wherein the DNA sequence encodes a polypeptide that produces an immune response to HER-2/neu protein, an...

이 특허에 인용된 특허 (9)

  1. Rubenstein Kenneth Edward (Palo Alto CA) Leute Richard K. (Sunnyvale CA). Antibody steric hindrance immunoassay with two antibodies. USP1976013935074.
  2. Carney Walter P. (North Andover MA) McKenzie Sara J. (Lynn MA). Detection and quantification of neu related proteins in the biological fluids of humans. USP1995035401638.
  3. Uzgiris Egidijus E. (Schenectady NY). Electrophoretic method of detecting antigen-antibody reaction. USP1976103984533.
  4. Gordon Julian (Arlesheim CHX) Staehelin Theophil (Arlesheim CHX) Towbin Harry (Allschwil CHX). Electrophoretically transferring electropherograms to nitrocellulose sheets for immuno-assays. USP1984064452901.
  5. Ullman Edwin F. (Atherton CA) Schwarzberg Moshe (Palo Alto CA). Fluorescence quenching with immunological pairs in immunoassays. USP1976123996345.
  6. Cheever, Martin A.; Peace, David J.. Immune reactivity to expressed activated oncogenes for diagnosis of malignancy. USP1994065320947.
  7. Maggio Edward T. (Redwood City CA) Wife Richard L. (Sittingbourne CA GB2) Ullman Edwin F. (Atherton CA). Reagents and method employing channeling. USP1980114233402.
  8. Piasio ; Roger N. ; Ryan ; James W. ; Woiszwillo ; James E.. Reverse sandwich immunoassay. USP1978074098876.
  9. Miles Laughton E. M. (Stanford CA). Universal reagent 2-site immunoradiometric assay using labelled anti (IgG). USP1977074034074.

이 특허를 인용한 특허 피인용횟수: 84

  1. Rosen, Craig A.; Haseltine, William A.. Albumin fusion proteins. USP2005086926898.
  2. Fendly,Brian M.. Anti-ErbB2 antibodies. USP2008057371376.
  3. Majumdar,Adhip P. N.; Sarkar,Fazlul H.. Antibodies to a novel EGF-receptor related protein (ERRP). USP2006057049410.
  4. Yu, John S.; Black, Keith L.; Liu, Gentao. CD133 epitopes. USP2015069068020.
  5. Yu, John S.; Black, Keith L.; Liu, Gentao. CD133 epitopes. USP2016079382308.
  6. Yu, John S.. Cancer stem cell antigen vaccines and methods. USP2015059023338.
  7. Yu, John S.. Cancer stem cell antigen vaccines and methods. USP2012038129184.
  8. Bender, James G.; Yu, John S.. Cancer vaccines and vaccination methods. USP20181110137182.
  9. Yu, John S.; Liu, Gentao; Black, Keith L.. Cancer vaccines and vaccination methods. USP20190310226519.
  10. Yu, John S.; Liu, Gentao; Black, Keith L.. Cancer vaccines and vaccination methods. USP2016099433667.
  11. Yu, John S.; Liu, Gentao; Black, Keith L.. Cancer vaccines and vaccination methods. USP2015089095538.
  12. Yu, John S.; Liu, Gentao; Black, Keith L.. Cancer vaccines and vaccination methods. USP2014108871211.
  13. Yu, John S.; Liu, Gentao; Black, Keith L.. Cancer vaccines and vaccination methods. USP2012018097256.
  14. Kaumaya, Pravin. Chimeric peptides comprising HER-2 B-cell epitopes and T-helper epitopes. USP2013068470333.
  15. Kaumaya, Pravin. Chimeric peptides comprising HER-2 B-cell epitopes and Tcell helper epitopes. USP2016099452204.
  16. Schultes, Birgit C.; Nicodemus, Christopher F.; Noujaim, Antoine A.; Madiyalakan, Ragupathy. Combination therapy for treating disease. USP2011108038994.
  17. Mass, Robert D.. Detection of ErbB2 gene amplification to increase the likelihood of the effectiveness of ErbB2 antibody breast cancer therapy. USP2011087993834.
  18. Baughman, Sharon A.; Shak, Steven. Dosages for treatment with anti-ErbB2 antibodies. USP2003096627196.
  19. Baughman,Sharon A.; Shak,Steven. Dosages for treatment with anti-ErbB2 antibodies. USP2008057371379.
  20. Greene, Mark I.; Murali, Ramachandran; Berezov, Alan; Liu, Qingdu; Chen, Jinqiu. ErbB interface peptidomimetics and methods of use thereof. USP2009127638598.
  21. Greene, Mark I.; Murali, Ramachandran; Zhang, Hongtao; Richter, Mark; Berezov, Alan; Liu, Qingdu; Chen, Jinqiu. ErbB interface peptidomimetics and methods of use thereof. USP2011118057799.
  22. Greene, Mark I.; Murali, Ramachandran; Zhang, Hongtao; Richter, Mark; Berezov, Alan; Liu, Qingdu; Chen, Jinqiu. ErbB interface peptidomimetics and methods of use thereof. USP2013058445644.
  23. Greene, Mark I.; Murali, Ramachandran; Zhang, Hongtao; Richter, Mark; Berezov, Alan; Liu, Qingdu; Chen, Jinqiu. ErbB interface peptidomimetics and methods of use thereof. USP2015028962793.
  24. Greene, Mark I.; Murali, Ramachandran; Hasegawa, Akihiro. Fas peptide mimetics and uses thereof. USP2014038680047.
  25. Mass, Robert D.. Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy. USP2013058440402.
  26. Mass, Robert D.. Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy. USP2011128076066.
  27. Mass, Robert D.. Gene detection assay for improving the likelihood of an effective response to an EGFR antagonist cancer therapy. USP2013118592152.
  28. Cheever, Martin A.; Gheysen, Dirk. HER-2/neu fusion proteins. USP2013108568733.
  29. Cheever,Martin A.; Gheysen,Dirk. HER-2/neu fusion proteins. USP2007047198920.
  30. Cheever,Martin A.; Gheysen,Dirk. HER-2/neu fusion proteins. USP2008057375091.
  31. Cheever,Martin A.; Gheysen,Dirk. Her-2/neu fusion proteins. USP2007067229623.
  32. Adams, Camellia W.; Presta, Leonard G.; Sliwkowski, Mark. Humanized anti-ERBB2 antibodies and treatment with anti-ERBB2 antibodies. USP2009057537931.
  33. Adams, Camellia W.; Presta, Leonard G.; Sliwkowski, Mark. Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies. USP2011017862817.
  34. Sliwkowski, Mark. Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies. USP2005096949245.
  35. Sutton, James; Xu, Feng; Valiante, Nicholas; Lan, Jiong. Imidazoquinoxaline compounds as immunomodulators. USP2012058173657.
  36. Pravin, Kaumaya. Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use. USP2016119504738.
  37. Sutton, James; Valiante, Nicholas. Immunopotentiating compounds. USP2011118063063.
  38. Bacus, Sarah S.; Lynch, David Haskett; Lockbaum, Pamela; Schwab, Gisela; Yang, Xiao-dong. Method for predicting response to epidermal growth factor receptor-directed therapy. USP2010087771958.
  39. Berinstein, Neil; Tartaglia, James; Moingeon, Philippe; Barber, Brian. Method of inducing and/or enhancing an immune response to tumor antigens. USP2011098017590.
  40. Kanner, Steven B.; Raitano, Arthur B.; Jakobovits, Aya; Challita Eid, Pia M.; Ge, Wangmao; Perez Villar, Juan J.. Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancer. USP2009127638270.
  41. Raitano, Arthur B.; Jakobovits, Aya; Challita-Eid, Pia M.; Ge, Wangmao; Perez-Villar, Juan J.; Kanner, Steven B.. Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancer. USP2013068460881.
  42. Kaumaya, Pravin. Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein. USP2012028110657.
  43. Kaumaya, Pravin T. P.. Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein. USP2010027666430.
  44. Kaumaya,Pravin T. P.; Stevens,Vernon C.; Triozzi,Pierre L.. Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein. USP2006067060284.
  45. Andya, James; Cleland, Jeffrey L.; Hsu, Chung C.; Lam, Xanthe M.; Overcashier, David E.; Shire, Steven J.; Yang, Janet Yu-Feng; Wu, Sylvia Sau-Yan. Protein formulation. USP2016039283273.
  46. Andya, James; Cleland, Jeffrey L.; Hsu, Chung C.; Lam, Xanthe M.; Overcashier, David E.; Shire, Steven J.; Yang, Janet Yu-Feng; Wu, Sylvia Sau-Yan. Protein formulation. USP2010037682609.
  47. Andya, James; Cleland, Jeffrey L.; Hsu, Chung C.; Lam, Xanthe M.; Overcashier, David E.; Shire, Steven J.; Yang, Janet Yu-Feng; Wu, Sylvia Sau-Yan. Protein formulation. USP2004026685940.
  48. Andya,James; Cleland,Jeffrey L.; Hsu,Chung C.; Lam,Xanthe M.; Overcashier,David E.; Shire,Steven J.; Yang,Janet Yu Feng; Wu,Sylvia Sau Yan. Protein formulation. USP2006067060268.
  49. Cleland, Jeffrey L.; Hsu, Chung C.; Lam, Xanthe M.; Overcashier, David E.; Yang, Janet Yu-Feng. Protein formulation. USP2004116821515.
  50. Van Berkel, Patricius Hendrikus Cornelis; Howard, Philip Wilson. Pyrrolobenzodiazepine-anti-CD22 antibody conjugates. USP2018039919056.
  51. Howard, Philip Wilson; Van Berkel, Patricius Hendrikus Cornelis. Pyrrolobenzodiazepine-antibody conjugates. USP20180710010624.
  52. Howard, Philip Wilson; Van Berkel, Patricius Hendrikus Cornelis. Pyrrolobenzodiazepine-antibody conjugates. USP2018049950078.
  53. Van Berkel, Patricius Hendrikus Cornelis; Howard, Philip Wilson. Pyrrolobenzodiazepine-antibody conjugates. USP2018049931414.
  54. Van Berkel, Patricius Hendrikus Cornelis; Howard, Philip Wilson. Pyrrolobenzodiazepine-antibody conjugates. USP2018049931415.
  55. Howard, Philip Wilson. Pyrrolobenzodiazepines and conjugates thereof. USP2018029889207.
  56. Howard, Philip Wilson. Pyrrolobenzodiazepines and conjugates thereof. USP20190110188746.
  57. Howard, Philip Wilson. Pyrrolobenzodiazepines and conjugates thereof. USP2017029562049.
  58. Howard, Philip Wilson; Ezeadi, Ebele; D'Hooge, Francois; Patel, Neki; Kemp, Gary. Pyrrolobenzodiazepines and conjugates thereof. USP20180710029018.
  59. Howard, Philip Wilson; Van Berkel, Patricius Hendrikus Cornelis. Pyrrolobenzodiazepine—antibody conjugates. USP2018059956299.
  60. Majumdar, Adhip P. N.. Recombinant DNA encoding an epidermal growth factor receptor related protein. USP2003066582934.
  61. Claudine Bruck BE; Teresa Cabezon Silva BE; Anne-Marie Eva Fernande Delisse BE; Catherine Marie Ghislaine Gerard BE; Angela Lombardo-Bencheikh BE. Recombinant papillomavirus vaccine and method for production and treatment. USP2002016342224.
  62. Monaci,Paolo; Nuzzo,Maurizio; La Monica,Nicola; Ciliberto,Gennaro; Lahm,Armin. Rhesus HER2/neu, nucleotides encoding same, and uses thereof. USP2007107282365.
  63. Monaci, Paolo; Gallo, Pasquale; Nuzzo, Maurizio. Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof. USP2010027662586.
  64. Nicolette, Charles A.. Therapeutic anti-melanoma compounds. USP2005036861408.
  65. Madiyalakan,Ragupathy; Noujaim,Antoine; Schultes,Birgit; Baum,Richard. Therapeutic compositions that alter the immune response. USP2008017318921.
  66. Madiyalakan,Ragupathy; Noujaim,Antoine A.; Baum,Richard P.; Schultes,Birgit; Leveugle,Beatrice; Kreutz,Fernando. Therapeutic compositions that produce an immune response. USP2008047361346.
  67. Nicolette, Charles A.. Therapeutic compounds. USP2003036528060.
  68. Andya, James; Hsu, Chung C.; Shire, Steven J.; Wu, Sylvia Sau-Yan. Treating a mammal with a formulation comprising an antibody which binds IgE. USP2015119180189.
  69. Sliwkowski,Mark X.. Treating prostate cancer with anti-ErbB2 antibodies. USP2006057041292.
  70. Baughman, Sharon A.; Shak, Steven. Treatment with anti-ErbB2 antibodies. USP20181210160811.
  71. Hellmann, Susan D.. Treatment with anti-ErbB2 antibodies. USP2010127846441.
  72. Hellmann, Susan D.. Treatment with anti-ErbB2 antibodies. USP2012118309087.
  73. Hellmann, Susan D.. Treatment with anti-ErbB2 antibodies. USP2013048425908.
  74. Hellmann, Susan D.. Treatment with anti-ErbB2 antibodies. USP2011128075892.
  75. Hellmann, Susan D.. Treatment with anti-ErbB2 antibodies. USP2014028642036.
  76. Paton, Virginia E.; Shak, Steven; Hellmann, Susan D.. Treatment with anti-ErbB2 antibodies. USP2011027892549.
  77. Sliwkowski, Mark. Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs. USP2009117618631.
  78. Adams,Camellia W.; Presta,Leonard G.; Sliwkowski,Mark. Treatment with anti-ErbB2 antibodies and anti-hormonal compounds. USP2009037498030.
  79. Adams,Camellia W.; Presta,Leonard G.; Sliwkowski,Mark. Treatment with anti-ErbB2 antibodies and chemotherapeutic agents. USP2009027485302.
  80. Adams,Camellia W.; Presta,Leonard G.; Sliwkowski,Mark. Treatment with anti-ErbB2 antibody combinations. USP2009037501122.
  81. Howard, Philip Wilson. Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases. USP2017029567340.
  82. O'Hagan, Derek; Van Nest, Gary; Ott, Gary S.; Barackman, John; Kazzaz, Jina. Use of microparticles with adsorbed antigen to stimulate immune responses. USP2009107597908.
  83. Zielinski,Christoph; Scheiner,Otto; Jensen Jarolim,Erika; Breiteneder,Heimo; Pehamberger,Hubert. Vaccine against cancer diseases that are associated with the her-2/neu oncogene. USP2008037348010.
  84. Zielinski,Christoph; Scheiner,Otto; Jensen Jarolim,Erika; Breiteneder,Heimo; Penamberger,Hubert. Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells. USP2007017166694.

IPC 상위 출원인